Informações:
Falhas:
ID
34165
Descrição
Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02275871
Link
https://clinicaltrials.gov/show/NCT02275871
Palavras-chave
Versões (1)
- 14/01/2019 14/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
14 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Breast Cancer NCT02275871
Eligibility Breast Cancer NCT02275871
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT02275871
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
women
boolean
ID.2
Item
age > or equal to 30 years
boolean
ID.3
Item
high risk (>20% lifetime risk)
boolean
ID.4
Item
has a bilateral mammogram within the last 7 months
boolean
ID.5
Item
has had a same day high risk screening mri
boolean
ID.6
Item
participants who have a known allergy or contraindication to iodinated contrast.
boolean
ID.7
Item
participants who have a known allergy to food or medications.
boolean
ID.8
Item
participants who have renal insufficiency or failure.
boolean
ID.9
Item
participants who are pregnant or breastfeeding.
boolean
ID.10
Item
participants with a concurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia.
boolean